RHO and colitis: Notably, experimental evidence from colitis models reveals that SSP treatment modulates the Rho/ROCK signaling pathway, enhances tight junction protein expression, preserves colonic mucosal barrier integrity, and prevents pathogenic infiltration, thereby ameliorating 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis (Zhang et al., 2021).